These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22207888)

  • 41. A Clinically Relevant Functional Model of Type-2 Cardio-Renal Syndrome with Paraventricular Changes consequent to Chronic Ischaemic Heart Failure.
    Harrison JC; Smart SDG; Besley EMH; Kelly JR; Read MI; Yao Y; Sammut IA
    Sci Rep; 2020 Jan; 10(1):1261. PubMed ID: 31988300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome.
    Jungbauer CG; Birner C; Jung B; Buchner S; Lubnow M; von Bary C; Endemann D; Banas B; Mack M; Böger CA; Riegger G; Luchner A
    Eur J Heart Fail; 2011 Oct; 13(10):1104-10. PubMed ID: 21846754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
    van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
    Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. When cardiac failure, kidney dysfunction, and kidney injury intersect in acute conditions: the case of cardiorenal syndrome.
    Legrand M; Mebazaa A; Ronco C; Januzzi JL
    Crit Care Med; 2014 Sep; 42(9):2109-17. PubMed ID: 24810531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies.
    Fu Q; Cao L; Li H; Wang B; Li Z
    Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.
    Atici A; Emet S; Cakmak R; Yuruyen G; Alibeyoglu A; Akarsu M; Arman Y; Kose M; Ozgun E; Ozcan M; Altun O; Onur I; Tukek T
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3534-3543. PubMed ID: 29917208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cardio-renal syndrome and anaemia].
    Jakić M
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():38-45. PubMed ID: 20232550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Pehlivanidis AN; Bouloukos VI; Elisaf M
    J Clin Pathol; 2004 Jul; 57(7):728-34. PubMed ID: 15220366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of Cardiorenal Syndrome.
    Rubinstein J; Sanford D
    Cardiol Clin; 2019 Aug; 37(3):267-273. PubMed ID: 31279420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidney Response to Heart Failure: Proteomic Analysis of Cardiorenal Syndrome.
    Melenovsky V; Cervenka L; Viklicky O; Franekova J; Havlenova T; Behounek M; Chmel M; Petrak J
    Kidney Blood Press Res; 2018; 43(5):1437-1450. PubMed ID: 30235455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiorenal syndrome: a complex series of combined heart/kidney disorders.
    Goh CY; Vizzi G; De Cal M; Ronco C
    Contrib Nephrol; 2011; 174():33-45. PubMed ID: 21921607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular apoptosis in the cardiorenal axis.
    Virzì GM; Clementi A; Ronco C
    Heart Fail Rev; 2016 Mar; 21(2):177-89. PubMed ID: 26852141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fabry's disease: an example of cardiorenal syndrome type 5].
    Villa G; Romagnoli S; Sharma A; Ronco C
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):131-141. PubMed ID: 28682034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets.
    Takahama H; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H715-H721. PubMed ID: 28733448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction.
    Guazzi M; Gatto P; Giusti G; Pizzamiglio F; Previtali I; Vignati C; Arena R
    Int J Cardiol; 2013 Nov; 169(6):379-84. PubMed ID: 24182905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cardiorenal syndrome: Clinical and echocardiographic aspects].
    Alprecht-Quiroz P; Zúñiga-Pineda B; Lara-Terán JJ; Cáceres-Vinueza SV; Duarte-Vera YC
    Arch Cardiol Mex; 2020; 90(4):503-510. PubMed ID: 33373357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [CARDIORENAL SYNDROME: CLINICAL FEATURES, EARLY DIAGNOSIS AND TREATMENT AT FAMILY MEDICINE].
    Marković BB
    Acta Med Croatica; 2016 Dec; 70(4-5):207-16. PubMed ID: 29087099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4.
    Edmonston D; Morris JD; Middleton JP
    Adv Chronic Kidney Dis; 2018 Sep; 25(5):454-467. PubMed ID: 30309463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardio-Pulmonary-Renal Consequences of Severe COVID-19.
    Guven G; Ince C; Topeli A; Caliskan K
    Cardiorenal Med; 2021; 11(3):133-139. PubMed ID: 34082420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle.
    Cicoira M; Anker SD; Ronco C
    J Cachexia Sarcopenia Muscle; 2011 Sep; 2(3):135-142. PubMed ID: 21966640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.